The most recent research indicates that temozolomide can suppress the growth of malignant glioma by inhibiting the expression of AQP4, implying that the AQP4 pathway’s activity substantially impacts the chemotherapeutic effectiveness of GBM (Chen et al., 2017). The gene discussed is AQP4; the disease is glioblastoma.